N-acetyl-S-(2-carbamoylethyl)-cysteine: The Urine Marker for Acrylamide Exposure
REVIEWED BY
William Maish, MD MBA MPH
Clinical Product Lead
Published
Last updated
Key takeaway:
This test measures urinary N-acetyl-S-(2-carbamoylethyl)-cysteine (AAMA), a key biomarker of acrylamide exposure from food, tobacco smoke, and workplaces. Identifying elevated exposure helps you take action to reduce risks linked to acrylamide, including increased cancer risk and neurotoxic effects like nerve damage.
N-acetyl-S-(2-carbamoylethyl)-cysteine is a urinary mercapturic acid biomarker most often called AAMA. It is the major metabolite your body makes after exposure to acrylamide, a small industrial and dietary chemical found in cigarette smoke and formed when starchy foods are cooked at high temperatures (think crispy fries, potato chips, well-toasted bread, and some coffees). Acrylamide can also be present in certain workplaces that use grouts or resins. Labs typically measure AAMA in urine using LC-MS/MS. Because it is a downstream metabolite cleared in urine, AAMA reflects recent exposure over the past few days rather than a long-term body burden.
Thanks for signing up!
Check your inbox — your first issue is on the way. We send clinically reviewed health science, never spam.
Why acrylamide exposure is worth measuring
Why it matters: acrylamide can be absorbed by ingestion and inhalation, then distributed through the bloodstream. The liver handles it in two main ways. One pathway converts acrylamide to glycidamide, a reactive epoxide that can form DNA adducts; another couples acrylamide to glutathione, producing AAMA that the kidneys excrete. These processes touch core biology — oxidative stress, DNA interaction, and neural function. Animal and human data support neurotoxicity at higher exposures, and major agencies classify acrylamide as a probable human carcinogen, though everyday dietary exposures are far lower and individual risk depends on dose and duration.
Acrylamide’s biology connects directly to questions people actually have: Is my crispy‑food habit showing up in my body? Is secondhand or firsthand smoke driving extra load on my detox systems? Could workplace contact be nudging my nervous system? Measuring AAMA helps separate incidental contact from sustained exposure. Levels that cluster near population norms often indicate intermittent, low-dose intake from common foods. Higher or persistent readings can flag ongoing sources — for example, regular smoking, frequent high-heat cooking, or specific occupational settings. Testing is especially informative during pregnancy or fertility planning because acrylamide crosses the placenta and the fetal nervous system is developing rapidly, even though individual studies vary and more research is needed.
Reading an AAMA result
Laboratories report urinary AAMA with population-based reference ranges, often adjusted for urine dilution using creatinine. For environmental toxins, lower values are generally preferable when feasible. Because AAMA reflects what has happened recently, a clinician's interpretation is strongest when paired with notes on your last few days of diet, smoke exposure, and work routines, plus repeat testing to observe stability or change.
Relatively lower values usually point to limited recent acrylamide exposure and less likelihood of short-term system stress. In plain terms, it suggests that, over the last few days, your diet, air, and environment did not deliver much acrylamide into circulation. In pregnancy and early childhood, keeping exposures modest is generally considered prudent because developing systems are more vulnerable, even though absolute risk at dietary levels remains a matter of dose and duration.
Relatively higher values can indicate recent or ongoing exposure. That can place demand on glutathione-dependent detox pathways in the liver and shift workload to the kidneys for clearance. Depending on context, the nervous system is the most established target at higher doses, so symptoms like tingling or coordination changes warrant clinical assessment if present. Smokers often have higher AAMA than nonsmokers because smoke is a dense source. If levels remain elevated across time points, that pattern supports a search for recurrent contributors and, when appropriate, measurement of related metabolites to map the acrylamide–glycidamide balance.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Zooming out, AAMA results are one piece of a bigger picture. Environmental exposures rarely act alone. Patterns across multiple toxins, combined with general health markers (liver and kidney function, inflammatory signals) and your lived context, give the best read on risk over time. Watching trends is key: repeated measurements before and after changes in products or cooking methods help distinguish a transient spike from a true pattern that merits further evaluation with your clinician.
What an AAMA test can and can't tell you
Big picture: an environmental toxin test is most meaningful alongside related biomarkers, your overall health profile, and what is happening in your daily life. Over time, that combination helps separate short-lived spikes from persistent exposure patterns and supports smarter, safer choices with a clinician’s guidance.
Frequently Asked Questions
This test measures urinary N-acetyl-S-(2-carbamoylethyl)-cysteine, a mercapturic acid metabolite of acrylamide and therefore an exposure biomarker.
It reflects recent internal exposure to acrylamide from diet, tobacco smoke, or occupational sources because acrylamide is conjugated with glutathione and excreted as this mercapturate; measured levels are used in biomonitoring to estimate absorbed dose and metabolic processing.
N‑acetyl‑S‑(2‑carbamoylethyl)‑cysteine is a urinary mercapturic acid that indicates internal exposure to acrylamide (and its reactive metabolite glycidamide), so it matters because acrylamide is classified as a probable human carcinogen and can cause neurotoxic and reproductive effects at higher exposures; measuring this metabolite gives a direct readout of absorbed dose and how the body is detoxifying the chemical, which is relevant to long‑term health and longevity risk management. Potential sources include heat‑treated starchy foods (e.g., fried or baked potatoes and processed cereals), tobacco smoke, and certain industrial settings that use or produce acrylamide or polyacrylamide; health impacts of concern are cancer risk (based on animal data and mechanistic evidence), neurotoxicity, and possible reproductive effects; testing (usually urine LC‑MS/MS) helps quantify exposure, identify dominant sources (diet, smoking, workplace) and track the effectiveness of exposure‑reduction measures.
Testing is most useful for people with higher environmental or occupational exposure risk (manufacturing, wastewater treatment, or lab work), regular smokers, those who consume lots of fried/starchy processed foods, individuals with unexplained neurological or reproductive concerns, and people focused on optimizing detox capacity or longevity who want objective biomonitoring to guide practical reductions; results are informational rather than diagnostic and can help prioritize source control and behavior changes.
Typically you would test once to establish a baseline exposure level; if results are elevated, perform periodic follow-up monitoring (commonly every 3–6 months, or as recommended by your clinician) until levels fall or exposures are controlled, and consider annual checks for ongoing risk—also retest after changes in lifestyle or environment, for example "after changing household products" or "following detoxification efforts."
Several factors can alter N-acetyl-S-(2-carbamoylethyl)-cysteine test results: timing of sample collection relative to exposure, recent exposure from food, air, water or consumer products, individual metabolism (including genetic differences), hydration status, and the sample type analyzed (urine vs blood); certain medications or dietary supplements may also influence readings and should be reported to the laboratory.
No special medical preparations are usually required for N‑acetyl‑S‑(2‑carbamoylethyl)‑cysteine (AAMA) urine testing: fasting is not routinely necessary. Many labs accept a spot urine sample; a first‑morning void can be helpful for consistency and to reduce within‑day variability because it is more concentrated and reflects overnight exposures. If possible, avoid known high‑acrylamide sources (e.g., smoking and heavy consumption of fried or baked starchy foods) or occupational contact with acrylamide/plastics for 24–48 hours before sampling, unless your clinician or the laboratory gives different instructions.
Before the test, record any recent product use or environmental contact that could affect results — for example handling plastics, solvents or adhesives, use of personal care products, pesticide application, or smoking — and tell the laboratory or clinician, as this information helps interpret the measured urinary mercapturic acid levels. Follow any specific collection or timing instructions provided by the testing lab.
The N‑acetyl‑S‑(2‑carbamoylethyl)‑cysteine test is a reliable biomarker of recent exposure when measured by validated laboratory methods; it detects a specific mercapturic acid metabolite produced after exposure and therefore primarily reflects recent or short‑term exposure rather than long‑term body burden or historic exposures.
If your N‑acetyl‑S‑(2‑carbamoylethyl)‑cysteine level is higher than the reference range, it most commonly suggests greater recent exposure to its parent chemical (for example acrylamide from certain fried/roasted foods, cigarette smoke, or some occupational sources) or reduced removal from the body (for example slower metabolism or impaired kidney function). High results indicate a larger body burden and warrant checking possible exposure sources, reviewing smoking and diet, considering workplace protections, and discussing repeat testing and kidney/metabolic evaluation with your clinician.
If your level is below the reference range, it usually means lower recent exposure or faster clearance, though lab variability or differences in how your body processes and conjugates the chemical can also play a role. Either high or low results should not be interpreted alone — they are most useful when considered together with other toxin measurements, lifestyle factors (diet, smoking), medical history, and other health markers; your healthcare provider can put the result into context and recommend any follow‑up or exposure‑reduction steps.
N‑acetyl‑S‑(2‑carbamoylethyl)‑cysteine is a urinary mercapturic acid used as a biomarker of recent exposure to its parent electrophile; higher concentrations generally indicate greater recent exposure. Interpret your result against the lab’s reference interval and note whether the value is reported as concentration (e.g., µg/L) or normalized to urine creatinine or specific gravity (e.g., µg/g creatinine), since normalization corrects for urine dilution. A single elevated value most often reflects recent or acute exposure, whereas low or borderline values do not exclude intermittent or past exposures—serial measurements are more informative than a single result.
Always consider results in context: compare with related toxin markers and relevant body‑system indicators (liver and kidney function tests, and oxidative‑stress or inflammation biomarkers) and review known exposure sources (occupational, environmental, smoking, dietary). Emphasize trends over time and clinical context—rising levels suggest ongoing exposure or altered clearance, while falling levels suggest removal of the source or recovery. Discuss results with your clinician or occupational health specialist to determine the need for repeat testing, exposure mitigation, or further medical evaluation.
